Annual EBIT
-$16.35 M
-$5.62 M-52.38%
December 31, 2023
Summary
- As of February 8, 2025, LPCN annual earnings before interest & taxes is -$16.35 million, with the most recent change of -$5.62 million (-52.38%) on December 31, 2023.
- During the last 3 years, LPCN annual EBIT has risen by +$4.23 million (+20.54%).
- LPCN annual EBIT is now -314348.08% below its all-time high of -$5200.00, reached on December 31, 2011.
Performance
LPCN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.63 M
+$662.10 K+20.11%
September 30, 2024
Summary
- As of February 8, 2025, LPCN quarterly earnings before interest & taxes is -$2.63 million, with the most recent change of +$662.10 thousand (+20.11%) on September 30, 2024.
- Over the past year, LPCN quarterly EBIT has dropped by -$1.62 million (-159.49%).
- LPCN quarterly EBIT is now -120.78% below its all-time high of $12.66 million, reached on December 31, 2021.
Performance
LPCN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$3.71 M
+$4.41 M+54.30%
September 30, 2024
Summary
- As of February 8, 2025, LPCN TTM earnings before interest & taxes is -$3.71 million, with the most recent change of +$4.41 million (+54.30%) on September 30, 2024.
- Over the past year, LPCN TTM EBIT has increased by +$12.64 million (+77.28%).
- LPCN TTM EBIT is now -189.40% below its all-time high of $4.15 million, reached on September 30, 2022.
Performance
LPCN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LPCN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.4% | -159.5% | +77.3% |
| 3 y3 years | +20.5% | +33.5% | +71.3% |
| 5 y5 years | -44.4% | +33.5% | +71.3% |
LPCN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3694.7% | at low | -120.8% | +62.6% | -189.4% | +78.9% |
| 5 y | 5-year | -3694.7% | +20.5% | -120.8% | +62.6% | -189.4% | +82.0% |
| alltime | all time | <-9999.0% | +22.9% | -120.8% | +62.8% | -189.4% | +84.5% |
Lipocine EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.63 M(-20.1%) | -$3.71 M(-54.3%) |
| Jun 2024 | - | -$3.29 M(-202.2%) | -$8.13 M(-7.5%) |
| Mar 2024 | - | $3.22 M(-417.9%) | -$8.79 M(-46.2%) |
| Dec 2023 | -$16.35 M(+52.4%) | -$1.01 M(-85.6%) | -$16.35 M(-6.9%) |
| Sep 2023 | - | -$7.04 M(+78.1%) | -$17.57 M(+35.8%) |
| Jun 2023 | - | -$3.96 M(-8.8%) | -$12.93 M(+11.5%) |
| Mar 2023 | - | -$4.34 M(+94.6%) | -$11.60 M(+8.1%) |
| Dec 2022 | -$10.73 M(+2390.3%) | -$2.23 M(-7.5%) | -$10.73 M(-358.3%) |
| Sep 2022 | - | -$2.41 M(-8.2%) | $4.15 M(+17.8%) |
| Jun 2022 | - | -$2.62 M(-24.3%) | $3.53 M(-687.8%) |
| Mar 2022 | - | -$3.47 M(-127.4%) | -$600.10 K(+39.3%) |
| Dec 2021 | -$430.90 K(-97.9%) | $12.66 M(-516.8%) | -$430.90 K(-97.5%) |
| Sep 2021 | - | -$3.04 M(-55.0%) | -$17.52 M(-6.4%) |
| Jun 2021 | - | -$6.75 M(+104.7%) | -$18.71 M(+2.6%) |
| Mar 2021 | - | -$3.30 M(-25.5%) | -$18.24 M(-11.4%) |
| Dec 2020 | -$20.58 M(+68.1%) | -$4.43 M(+4.8%) | -$20.58 M(+6.7%) |
| Sep 2020 | - | -$4.23 M(-32.7%) | -$19.29 M(+7.5%) |
| Jun 2020 | - | -$6.28 M(+11.4%) | -$17.93 M(+20.5%) |
| Mar 2020 | - | -$5.64 M(+79.7%) | -$14.88 M(+21.5%) |
| Dec 2019 | -$12.24 M(+8.1%) | -$3.14 M(+9.1%) | -$12.24 M(-3.0%) |
| Sep 2019 | - | -$2.88 M(-10.8%) | -$12.62 M(+5.3%) |
| Jun 2019 | - | -$3.23 M(+7.5%) | -$11.98 M(+1.5%) |
| Mar 2019 | - | -$3.00 M(-14.6%) | -$11.80 M(+4.2%) |
| Dec 2018 | -$11.33 M | -$3.51 M(+56.9%) | -$11.33 M(-15.3%) |
| Sep 2018 | - | -$2.24 M(-26.4%) | -$13.38 M(-15.5%) |
| Jun 2018 | - | -$3.04 M(+20.5%) | -$15.84 M(-16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$2.53 M(-54.6%) | -$18.88 M(-11.2%) |
| Dec 2017 | -$21.22 M(+15.0%) | -$5.57 M(+18.5%) | -$21.27 M(+15.8%) |
| Sep 2017 | - | -$4.70 M(-22.8%) | -$18.37 M(+10.9%) |
| Jun 2017 | - | -$6.09 M(+24.1%) | -$16.57 M(+1.7%) |
| Mar 2017 | - | -$4.91 M(+83.7%) | -$16.30 M(-11.7%) |
| Dec 2016 | -$18.46 M(+0.4%) | -$2.67 M(-7.9%) | -$18.46 M(-9.9%) |
| Sep 2016 | - | -$2.90 M(-50.1%) | -$20.48 M(-14.7%) |
| Jun 2016 | - | -$5.82 M(-17.8%) | -$24.02 M(+6.8%) |
| Mar 2016 | - | -$7.07 M(+50.6%) | -$22.48 M(+22.3%) |
| Dec 2015 | -$18.38 M(-10.2%) | -$4.70 M(-27.0%) | -$18.38 M(+3.6%) |
| Sep 2015 | - | -$6.43 M(+50.4%) | -$17.75 M(+15.0%) |
| Jun 2015 | - | -$4.28 M(+43.8%) | -$15.43 M(-15.0%) |
| Mar 2015 | - | -$2.97 M(-26.7%) | -$18.16 M(-11.3%) |
| Dec 2014 | -$20.48 M(+133.8%) | -$4.06 M(-1.4%) | -$20.48 M(+2.8%) |
| Sep 2014 | - | -$4.12 M(-41.2%) | -$19.92 M(+7.4%) |
| Jun 2014 | - | -$7.01 M(+32.4%) | -$18.55 M(+60.7%) |
| Mar 2014 | - | -$5.29 M(+51.3%) | -$11.55 M(+84.5%) |
| Dec 2013 | -$8.76 M(>+9900.0%) | -$3.50 M(+27.2%) | -$6.26 M(-17.6%) |
| Sep 2013 | - | -$2.75 M(>+9900.0%) | -$7.59 M(+29.7%) |
| Jun 2013 | - | -$3100.00(-3.1%) | -$5.85 M(-1.0%) |
| Mar 2013 | - | -$3200.00(-99.9%) | -$5.91 M(-0.0%) |
| Dec 2012 | -$76.70 K(+1375.0%) | -$4.83 M(+376.2%) | -$5.91 M(+447.1%) |
| Sep 2012 | - | -$1.01 M(+1558.5%) | -$1.08 M(+1537.9%) |
| Jun 2012 | - | -$61.20 K(+1175.0%) | -$66.00 K(+1275.0%) |
| Mar 2012 | - | -$4800.00 | -$4800.00 |
| Dec 2011 | -$5200.00 | - | - |
FAQ
- What is Lipocine annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lipocine?
- What is Lipocine annual EBIT year-on-year change?
- What is Lipocine quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lipocine?
- What is Lipocine quarterly EBIT year-on-year change?
- What is Lipocine TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lipocine?
- What is Lipocine TTM EBIT year-on-year change?
What is Lipocine annual earnings before interest & taxes?
The current annual EBIT of LPCN is -$16.35 M
What is the all time high annual EBIT for Lipocine?
Lipocine all-time high annual earnings before interest & taxes is -$5200.00
What is Lipocine annual EBIT year-on-year change?
Over the past year, LPCN annual earnings before interest & taxes has changed by -$5.62 M (-52.38%)
What is Lipocine quarterly earnings before interest & taxes?
The current quarterly EBIT of LPCN is -$2.63 M
What is the all time high quarterly EBIT for Lipocine?
Lipocine all-time high quarterly earnings before interest & taxes is $12.66 M
What is Lipocine quarterly EBIT year-on-year change?
Over the past year, LPCN quarterly earnings before interest & taxes has changed by -$1.62 M (-159.49%)
What is Lipocine TTM earnings before interest & taxes?
The current TTM EBIT of LPCN is -$3.71 M
What is the all time high TTM EBIT for Lipocine?
Lipocine all-time high TTM earnings before interest & taxes is $4.15 M
What is Lipocine TTM EBIT year-on-year change?
Over the past year, LPCN TTM earnings before interest & taxes has changed by +$12.64 M (+77.28%)